PKI - PerkinElmer, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• PerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of $674.86M misses by $3.75M
• PerkinElmer declares $0.07 dividend
• Exact upgraded, Guardant downgraded as Citi revisits diagnostics coverage
• PerkinElmer Non-GAAP EPS of $1.70 beats by $0.04, revenue of $1.09B beats by $20M, Initiates FY23 guidance
• PerkinElmer Q4 2022 Earnings Preview
• PerkinElmer declares $0.07 dividend
• Danaher earnings weigh on other life sciences tools, services companies
• Goldman tips stocks poised to best benefit from China's reopening
• NIH outlays fall, US govt healthcare grants grow but Biopharma financings decline Y/Y
• PerkinElmer says Q4 results will meet or exceed prior guidance
• PerkinElmer launches ready-to-use AAV detection kits for use in gene therapies
• PerkinElmer receives FDA approval for EONIS assay for spinal muscular atrophy in newborns
• PerkinElmer reports mixed Q3 earnings, initiates Q4 and updates FY22 pro forma guidance
• PerkinElmer declares $0.07 dividend
• PerkinElmer expects Q3 earnings to exceed prior outlook
• FDA updates COVID-19 test policy to cut emergency use requests
• PerkinElmer gets FDA approval for T-Cell Select kit to automate TB test
• August U.S. healthcare govt grants, clinical trials & NIH outlays increase Y/Y, says Baird
• July U.S. healthcare govt grants, clinical trials increase vs June, says Baird
• PerkinElmer downgraded to hold at Stifel on CFO departure